<section id="ct" class="section">
    <nav class="desktop">
        <a href="" ui-sref="MOA" class="moa">
            <i class="fas fa-atom"></i>
        </a>
        <a href="" ui-sref="CT" class="ct active">
            <i class="fas fa-users"></i>
        </a>
        <a href="" ui-sref="EFFICACY" class="efficacy">
            <i class="fas fa-chart-line"></i>
        </a>
        <a href="" ui-sref="SAFETY" class="safety">
            <i class="fas fa-exclamation-triangle"></i>
        </a>
        <a href="" ui-sref="DOSING" class="dosing">
            <i class="fas fa-prescription"></i>
        </a>
    </nav>
    <main>
    <div class="top">
        <a href="" ui-sref="LANDING-PAGE"><img src="assets/pfizer-logo.svg" alt="Pfizer Logo"></a>
        <h1>Tofacitinib pcJIA</h1>
    </div>
    <div class="content">
        <a href="" ui-sref="STUDY-DESIGN" class="back-btn">
            <i class="fas fa-arrow-circle-left"></i>
            <h5 class="ct-header">BACK</h5>
        </a>
        <h3 class="ct-header">DOSAGE REGIMEN</h3>
        <p>To control for type 1 error, primary and key secondary endpoints were tested sequentially using a step down approach.
        </p>
        <p>Statistical significance (P &lt;0.05) could be claimed for the next endpoint only if the prior endpoint in the sequence met significance requirements.</p>
        <div class="img-wrapper">
            <img src="assets/ct/statistical-analysis-mobile.png" alt="Statistical Analysis" />
        </div>
        <p>The time to event analyses (e.g., time to flare) used Kaplan-Meier methodology and the log rank test.</p>
        <div class="footnotes">
            <p>ACR, American College of Rheumatology; CHAQ-DI, Childhood Health Assessment Questionnaire Disability Index; JIA, juvenile idiopathic arthritis; pcJIA, polyarticular course juvenile idiopathic arthritis.</p>
            <p>Data on file. Pfizer Inc., New York, NY. 2022</p>
        </div>
    </div>
    </main>
</div>
    <nav class="mobile">
        <a href="" class="moa">
            <i class="fas fa-atom"></i>
            <h5>MOA</h5>
        </a>
        <a href="" class="ct active">
            <i class="fas fa-users"></i>
            <h5>Clinical Trials</h5>
        </a>
        <a href="" class="efficacy">
            <i class="fas fa-chart-line"></i>
            <h5>Efficacy</h5>
        </a>
        <a href="" class="safety">
            <i class="fas fa-exclamation-triangle"></i>
            <h5>Safety</h5>
        </a>
        <a href="" class="dosing">
            <i class="fas fa-prescription"></i>
            <h5>Dosing</h5>
        </a>
    </nav>
</section>